Novo Nordisk and Eli Lilly are both raking in billions from their blockbuster weight loss drugs that are also approved to treat type 2 diabetes. Novo's drugs Ozempic and Wegovy are household names ...
You'll probably recognize their names after seeing them in the news or across social media: Ozempic and Wegovy (made by Novo ...
In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...
Since its approval in mid-March of 2024, sales of Rezdiffra are increasing expediciously, reaching $62.2 million in Q3, the ...
Excitement is building around a new weight loss drug, CagriSema, which is expected to surpass the effects of popular drugs ...